BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1753 related articles for article (PubMed ID: 17555895)

  • 1. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel.
    Jackson JK; Smith J; Letchford K; Babiuk KA; Machan L; Signore P; Hunter WL; Wang K; Burt HM
    Int J Pharm; 2004 Sep; 283(1-2):97-109. PubMed ID: 15363506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release.
    Liggins RT; Burt HM
    Int J Pharm; 2004 Sep; 282(1-2):61-71. PubMed ID: 15336382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
    Dong Y; Feng SS
    Int J Pharm; 2007 Sep; 342(1-2):208-14. PubMed ID: 17560058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
    Sinha VR; Trehan A
    Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.
    Xie J; Wang CH
    Pharm Res; 2006 Aug; 23(8):1817-26. PubMed ID: 16841195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations.
    Liggins RT; Burt HM
    Adv Drug Deliv Rev; 2002 Feb; 54(2):191-202. PubMed ID: 11897145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers.
    Mu L; Feng SS
    J Control Release; 2001 Oct; 76(3):239-54. PubMed ID: 11578739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide).
    Zweers ML; Engbers GH; Grijpma DW; Feijen J
    J Control Release; 2004 Dec; 100(3):347-56. PubMed ID: 15567501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
    Passerini N; Craig DQ
    J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres.
    Dong CM; Guo YZ; Qiu KY; Gu ZW; Feng XD
    J Control Release; 2005 Sep; 107(1):53-64. PubMed ID: 16005093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
    Woo BH; Jiang G; Jo YW; DeLuca PP
    Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.
    Xie J; Wang CH
    Pharm Res; 2005 Dec; 22(12):2079-90. PubMed ID: 16132339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
    Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
    Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.